Alice Nettleton
Stock Analyst at UBS
(n/a)
n/a
Analyst rank
3
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alice Nettleton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Initiated: Hold | $53 | $41.17 | +28.73% | 1 | Oct 12, 2026 | |
| PTGX Protagonist Therapeutics | Initiated: Buy | $184 | $143.73 | +28.02% | 1 | Oct 12, 2026 | |
| ODTX Odyssey Therapeutics | Initiated: Buy | $27 | $19.00 | +42.11% | 1 | Oct 12, 2026 |
Nektar Therapeutics
Oct 12, 2026
Initiated: Hold
Price Target: $53
Current: $41.17
Upside: +28.73%
Protagonist Therapeutics
Oct 12, 2026
Initiated: Buy
Price Target: $184
Current: $143.73
Upside: +28.02%
Odyssey Therapeutics
Oct 12, 2026
Initiated: Buy
Price Target: $27
Current: $19.00
Upside: +42.11%